Monthly Archives: July 2015

USD/MXN Continues To Show Real Strength

The USD/MXN rose during the course of the session on Wednesday, breaking above the 16.11 level. This coincides nicely with a significant breakdown in the oil markets, as we found ourselves trading below $50 for the first time in ages. With this, it makes sense if the Mexican peso should continue to break down overall,…

“No Longer Confined To The Lunatic Fringe”: SocGen Ad

Perhaps the most interesting thing about China’s “unprecedented” plunge protection efforts – which, as we outlined on Wednesday, have succeeded in making China Securities Finance Corp. a top-10 shareholder in at least eight firms – is that in some ways, they aren’t “unprecedented” at all. That is, while some of what we’ve seen out of Beijing over…

Recent Data Points To A Rebounding US Housing Market

The housing market continue to show signs of recovery after a soft first quarter. The latest hint: yesterday’s better-than-expected rise in existing home sales. Purchases advanced at the strongest pace in over eight years, reaching a new post-recession seasonally adjusted high of 5.49 million units in June. The update follows last week’s bullish news that new residential…

Will Big Changes Fuel Turnaround At McDonald’s?

McDonald’s Corporation (MCD) is expected to report second-quarter earnings today before markets open. MCD has missed both Estimize and Wall Street consensus for the past 5 consecutive quarters as consumers and investors’ confidence shrinks. Estimize currently has 35 estimates for McDonalds, and is predicting an EPS figure of $1.25 compared to Wall Street’s $1.23 estimate, both…

Thursday Morning’s Pre-Market Insights: KERX, SNDK, QCOM, And CRU...

Keryx Biopharmaceuticals (KERX) shares fell more than -5% in pre-market trading down to $9.06 after Boris Peaker at Cowen & Co. downgraded the company from Outperform to Market Perform. The analyst commented that Auryxia adoption will likely miss expectations. Auryxia is Keryx’s lead product used to treat patients with chronic kidney disease who are on dialysis. The analyst…